Cremona TP, Tschanz SA, von Garnier C, Benarafa C. SerpinB1 deficiency is not associated with increased susceptibility to pulmonary emphysema in mice. Am J Physiol Lung Cell Mol Physiol 305: L981-L989, 2013. First published October 25, 2013 doi:10.1152/ajplung.00181.2013.-Chronic obstructive pulmonary disease (COPD) is characterized by emphysema and chronic bronchitis and is a leading cause of morbidity and mortality worldwide. Tobacco smoke and deficiency in ␣1-antitrypsin (AAT) are the most prominent environmental and genetic risk factors, respectively. Yet the pathogenesis of COPD is not completely elucidated. Disease progression appears to include a vicious circle driven by self-perpetuating lung inflammation, endothelial and epithelial cell death, and proteolytic degradation of extracellular matrix proteins. Like AAT, serpinB1 is a potent inhibitor of serine proteases including neutrophil elastase and cathepsin G. Because serpinB1 is expressed in myeloid and lung epithelial cells and is protective during lung infections, we investigated the role of serpinB1 in preventing age-related and cigarette smoke-induced emphysema in mice. Fifteen-month-old mice showed increased lung volume and decreased pulmonary function compared with young adult mice (3 mo old), but no differences were observed between serpinB1-deficient (KO) and wild-type (WT) mice. Chronic exposure to secondhand cigarette smoke resulted in structural emphysematous changes compared with respective control mice, but no difference in lung morphometry was observed between genotypes. Of note, the different pattern of stereological changes induced by age and cigarette smoke suggest distinct mechanisms leading to increased airway volume. Finally, expression of intracellular and extracellular protease inhibitors were differently regulated in lungs of WT and KO mice following smoke exposure; however, activity of proteases was not significantly altered. In conclusion, we showed that, although AAT and serpinB1 are similarly potent inhibitors of neutrophil proteases, serpinB1 deficiency is not associated with more severe emphysema. serpin; cigarette smoke; animal model THIS YEAR MARKS the 50th anniversary of the landmark study by Laurell and Eriksson (33) that describes the association between reduced levels of the plasma protein ␣1-antitrypsin (AAT) and early development of severe pulmonary emphysema. The characterization of AAT as a major inhibitor of neutrophil elastase (NE) and the replication of features of emphysema following instillation of NE in the lungs of laboratory animals have been fundamental evidence in support of the protease-antiprotease theory of emphysema development (28,29,43,45,51,52). According to the theory, unopposed proteolytic activity of NE against elastin in the lungs leads to the degradation of this essential extracellular matrix protein, which normally provides the vital elastic properties of the lungs. Studies using animal models and knockout mice have helped extend and refine the protease-antiprotease theory beyond NE and AAT...